Bill > H2372

This bill aims to expand collaborative drug therapy management (CDTM) in ambulatory care clinics by allowing pharmacists to work more closely with physicians in managing patient medications. Specifically, the bill permits CDTM in ambulatory care clinics under two key conditions: first, the pharmacist must have either on-site or off-site supervision from the attending physician, and second, the clinic's medical staff executive committee, designee, or medical director must approve the collaborative drug therapy management approach. This legislation represents a modification to existing laws that previously may have restricted such collaborative practices, potentially improving patient care by enabling more integrated medication management between physicians and pharmacists in outpatient clinic settings.

Health and Social Services

https://malegislature.gov/Bills/194/H2372